Oslo University Hospital
Industry
- Academic and Research Institutions
See more in Biomedtracker
Latest on Oslo University Hospital
Scrip
• By Suzanne Elvidge
Norway-based Prophylix Pharma AS is set to be the first company to begin clinical trials for a prophylactic for FNAIT (fetal and neonatal alloimmune thrombocytopenia), a rare but serious disorder th
Scrip
• By Suzanne Elvidge
Vaccibody AS Oslo Research Park Gaustadalléen 21 0349 Oslo Norway Phone: +47 22 95 81 93 Web Site: www.vaccibody.com Contact: Ole Henrik Brekke, PhD, CEO Industry Segment: Biotechnology
Scrip
IN VITRO DIAGNOSTICS University of Oslo Inven2 AS Oslo University Hospital Oxford Gene Technology Ltd. Oxford Gene Technology licenses 12 cancer biomarkers from Inven2 Inven2 AS , the tech tr
Medtech Insight
Mergers & Acquisitions Alliances Financings Elsevier’s Strategic Transactions